# Study on the Registration of Coronary Heart Disease Patients Undergoing PCI

> **NCT02888652** · — · COMPLETED · sponsor: **The Third Xiangya Hospital of Central South University** · enrollment: 1500 (actual)

## Conditions studied

- Coronary Heart Disease

## Interventions

- **DRUG:** antiplatelet agents(Clopidogrel or Ticagrelor)

## Key facts

- **NCT ID:** NCT02888652
- **Lead sponsor:** The Third Xiangya Hospital of Central South University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2015-09
- **Primary completion:** 2018-08
- **Final completion:** 2018-10
- **Target enrollment:** 1500 (ACTUAL)
- **Last updated:** 2019-10-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02888652

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02888652, "Study on the Registration of Coronary Heart Disease Patients Undergoing PCI". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02888652. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*